BIOMAT Database Logo BIOMAT Database Logo

Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. 2009

Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Department of Cellular and Developmental Biology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, 407 South Goodwin Avenue, Urbana, Illinois 61801, USA.

Accumulation of reactive oxygen species (ROS) in cells damages resident proteins, lipids, and DNA. In order to overcome the oxidative stress that occurs with ROS accumulation, cells must balance free radical production with an increase in the level of antioxidant enzymes that convert free radicals to less harmful species. We identified two antioxidant enzymes, thioredoxin (Trx) and Trx reductase (TrxR), in a complex associated with the DNA-bound estrogen receptor alpha (ERalpha). Western analysis and immunocytochemistry were used to demonstrate that Trx and TrxR are expressed in the cytoplasm and in the nuclei of MCF-7 human breast cancer cells. More importantly, endogenously expressed ERalpha, Trx, and TrxR interact and ERalpha and TrxR associate with the native, estrogen-responsive pS2 and progesterone receptor genes in MCF-7 cells. RNA interference assays demonstrated that Trx and TrxR differentially influence estrogen-responsive gene expression and that together, 17beta-estradiol, Trx, and TrxR alter hydrogen peroxide (H(2)O(2)) levels in MCF-7 cells. Our findings suggest that Trx and TrxR are multifunctional proteins that, in addition to modulating H(2)O(2) levels and transcription factor activity, aid ERalpha in regulating the expression of estrogen-responsive genes in target cells.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D013879 Thioredoxins Hydrogen-donating proteins that participates in a variety of biochemical reactions including ribonucleotide reduction and reduction of PEROXIREDOXINS. Thioredoxin is oxidized from a dithiol to a disulfide when acting as a reducing cofactor. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE. Thioredoxin,Thioredoxin 1,Thioredoxin 2,Thioredoxin-1,Thioredoxin-2
D013880 Thioredoxin-Disulfide Reductase A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXINS to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5 Thioredoxin Reductase (NADPH),NADP-Thioredoxin Reductase,NADPH-Thioredoxin Reductase,Thioredoxin Reductase,NADP Thioredoxin Reductase,NADPH Thioredoxin Reductase,Reductase, NADP-Thioredoxin,Reductase, NADPH-Thioredoxin,Reductase, Thioredoxin,Reductase, Thioredoxin-Disulfide,Thioredoxin Disulfide Reductase
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Estrogen receptor-alpha regulates SOCS-3 expression in human breast cancer cells.
September 2005, Biochemical and biophysical research communications,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Estrogen and TCDD influence RLN2 gene activity in estrogen receptor-positive human breast cancer cells.
April 2009, Annals of the New York Academy of Sciences,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Regulation of estrogen receptor alpha expression in human breast cancer cells by sulforaphane.
March 2009, The Journal of nutritional biochemistry,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.
July 2006, The Journal of biological chemistry,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells.
January 2009, Oncology reports,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells.
August 2002, International journal of oncology,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Gene expression signature of estrogen receptor alpha status in breast cancer.
March 2005, BMC genomics,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells.
December 1999, Journal of molecular endocrinology,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
TGF-alpha exerts biphasic effects on estrogen--and phytoestrogen-mediated gene expression in breast cancer cells.
August 1999, Endocrine,
Abhi K Rao, and Yvonne S Ziegler, and Ian X McLeod, and John R Yates, and Ann M Nardulli
Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells.
October 2002, The Journal of biological chemistry,
Copied contents to your clipboard!